Docetaxel is a chemotherapy drug that is used to treat several forms of cancer including head and neck cancer. In October 2006, the United States Food and Drugs Administration (US FDA) approved the use of docetaxel in combination with cisplatin and fluorouracil as an induction therapy for locally advanced squamous cell cancers of the head and neck (also called SCCHN). […]

Continue reading »